CD4 and neoplasm: In addition to conventional T cells (CD4 and CD8 T cells), innate-like T cells, including MAIT cells, natural killer T (NKT) cells, and γδT cells, have been shown to play a pivotal role in tumor immunity, raising the possibility of using or targeting these cells in tumor therapy [3].